Mike Nall

Mr. Nall joined Biological Dynamics in 2022 and has been a leader in Healthcare and Biotech for over 30 years. Most recently he served as the President, CEO and Board Member at Biocept, a publicly traded cancer diagnostics company, where he led the company’s transition from R and D to full Commercialization. Prior to Biocept, he was at Clarient both before and after acquisition by GE Healthcare, serving in numerous executive and leadership roles. Other companies Mr. Nall has held leadership roles with include Impath, Maquet Surgical, Columbia Vital Systems and American Cyanamid Davis and Geck Surgical. He is currently serves on the boards of Nonigenex, a company focused on Maternal Fetal Health; Alacrity, an LA based digital health company; and Clearity Foundation, a non-profit dedicated to supporting women who have been diagnosed with Ovarian Cancer. He also serves on the Industry Relations Committee for the Moores Cancer Center.